Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
November 01, 2023 16:05 ET
|
Prelude Therapeutics, Inc.; AbCellera
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
October 30, 2023 06:00 ET
|
Turnstone Biologics Corp.
Internationally recognized cancer immunotherapy thought leader, Dr. Weber, will help guide Turnstone’s continued advancement of its Selected TIL therapies
Global Preclinical Imaging Market Set to Reach $5.95 Billion by 2030, Driven by Research and Development Investments
October 18, 2023 09:53 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Services, Ultrasound Imaging), By Application (Research and...
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
September 28, 2023 06:00 ET
|
Turnstone Biologics Corp.
Turnstone Biologics to present preclinical data for its Selected TILs at SITC's 38th Annual Meeting.
Global NSCLC Market Dynamics and Innovations: Striving to Transform Lung Cancer Treatment
September 05, 2023 09:51 ET
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global NSCLC Market Dynamics and Innovations: Striving to Transform Lung Cancer Treatment
September 05, 2023 09:49 ET
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Sermonix Pharmaceuticals Shares Encore ELAINE-2 Poster Presentation at 2023 Metastatic Breast Cancer Research Conference
September 05, 2023 09:00 ET
|
Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
September 01, 2023 17:57 ET
|
Turnstone Biologics Corp.
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position expected to fund operations into second quarter of...
Dr. Lyudmila Sarder Receives Rave Reviews from Lakeland Regional Health and AdventHealth Cancer Institute for Research
August 24, 2023 15:00 ET
|
Lakeland Regional Health
Lakeland, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- AdventHealth Cancer Institute proudly unveiled findings that mark a significant milestone in the cancer research field. Meanwhile, Lakeland Regional...
Dr. Lyudmila Sarder Receives Rave Reviews from Lakeland Regional Health and AdventHealth Cancer Institute for Research
August 22, 2023 14:55 ET
|
Lakeland Regional Health
Lakelan, FL, Aug. 22, 2023 (GLOBE NEWSWIRE) -- AdventHealth Cancer Institute proudly unveiled findings that mark a significant milestone in the cancer research field. Meanwhile, Lakeland Regional...